Wonbiogen Co.,Ltd. Logo

Wonbiogen Co.,Ltd.

Develops and manufactures advanced wound care solutions and medical materials.

307280 | KO

Overview

Corporate Details

ISIN(s):
KR7307280008
LEI:
Country:
South Korea
Address:
경상북도 구미시 1공단로5길 56 ㈜원바이오젠, 구미시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 2006, Wonbiogen Co., Ltd. is a bio-venture company specializing in the research, development, and manufacturing of advanced medical materials. The company's primary focus is on science-driven, advanced wound care solutions. Its product portfolio includes polyurethane foam dressings, hydrocolloid dressings, and soft silicone adhesive products under brands such as MEDISORB and RENODERM. These products are designed to treat a wide range of wounds, from cuts and burns to surgical sites and chronic ulcers. Wonbiogen leverages its expertise in developing highly biocompatible medical macromolecules to create innovative medical supplies and also offers OEM services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-27 00:00
Share Issue/Capital Change
[기재정정]주식소각결정
Korean 13.0 KB
2025-08-26 00:00
Regulatory Filings
신규시설투자등(자율공시)
Korean 7.5 KB
2025-08-25 00:00
Legal Proceedings Report
불성실공시법인미지정 (지정유예)
Korean 5.5 KB
2025-08-19 00:00
Share Issue/Capital Change
주식소각결정
Korean 9.9 KB
2025-08-13 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-01 00:00
Legal Proceedings Report
불성실공시법인지정예고 (공시불이행)
Korean 4.9 KB
2025-07-07 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(일정금액이상의청구)
Korean 7.2 KB
2025-07-07 00:00
Legal Proceedings Report
소송등의판결ㆍ결정
Korean 5.3 KB
2025-05-23 00:00
Delisting Announcement
주권매매거래정지해제 (액면병합 주권 변경상장)
Korean 4.3 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.2 MB
2025-04-29 00:00
Delisting Announcement
주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)
Korean 4.6 KB
2025-03-31 00:00
AGM Information
정기주주총회결과
Korean 21.2 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.0 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 441.3 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.6 KB

Automate Your Workflow. Get a real-time feed of all Wonbiogen Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Wonbiogen Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Wonbiogen Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America
ACRV
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America
ABOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.